Hospital-based care for hallucinogens and risk of mania and bipolar disorder: a population-based cohort study
Myran DT, MacDonald-Spracklin R, Pugliese M, Gibb M, Fiedorowicz JG, Kaster TS, Solmi M. PLoS Med. 2025; 22(12): e1004805.
Publications
Palliative care involvement and intensity of end-of-life care among adolescents and young adults with cancer: a population-based study
Abdelaal M, Parsons H, Srikanthan A, Al-Awamer A, Mosher PJ, Lapenskie J, Cleyn S, Fung SG, Yoo S, Dhaliwal S, Tanuseputro P, Downar J. CMAJ. 2025; 197(41): E1363-E1373.
Late pregnancy antiseizure medication exposure and offspring neurodevelopmental risk: a multi-child cohort study
Sheehy O, Tchuente V, Eltonsy S, Hawken S, Kaul P, Walker M, Pugliese M, Dragan R, Savu A, Leal L, Morin L, Malhamé I, Pana R, Bérard A. Ann Neurol. 2025; Nov 28 [Epub ahead of print].
Effect of nonmedical cannabis legalization and exposure to retail stores on cannabis harms: a quasi-experimental study
Friesen EL, Pugliese M, MacDonald-Spracklin R, Manuel D, Wilson K, Hobin E, Pinto AD, Myran DT. Ann Intern Med. 2025; Nov 25 [Epub ahead of print].
Health service utilization in children with permanent hearing loss: a nested case control study
Olds J, Fitzpatrick EM, Nicholls SG, Rosella LC, Spruin S, Pigeon M, Whittingham J, MacDougall J, Schramm D, Benchimol EI. Otol Neurotol. 2025; Nov 25 [Epub ahead of print].
COVID-19 infections still occur: How do pregnant and non-pregnant individuals compare? A study from the Canadian Mother-Child Initiative on Drug Safety in Pregnancy (CAMCCO)
Bérard A, Sheehy O, Kaul P, Eltonsy S, Walker M, Hawken S, Bernatsky S, Pugliese M, Barrett O, Savu A, Dragan R. Int J Environ Res Public Health. 2025; 22(11): 1756.
Patterns in mental health- and substance use-related visits from 2003 to 2022 among registered Ontario physicians
Gibb MA, Harrison L, Dumicho AY, Sood MM, Tanuseputro P, Moledina A, Tuna M, Halilou T, Kendall CE, Colman I, Fernando SM, Roberts RL, Maskerine C, Myran DT. Ann Intern Med. 2025; Nov 18 [Epub ahead of print].
A population-based matched cohort study of extra-digestive cancer incidence and mortality in individuals with and without inflammatory bowel disease
Murthy SK, Ahmed F, Pugliese M, Taljaard M, Tandon P, Matthews P, Kaplan GG, Coward S, Bernstein CN, Benchimol EI, Kuenzig ME, Targownik LE, Singh H; Canadian Gastro‐Intestinal Epidemiology Consortium (CanGIEC). Aliment Pharmacol Ther. 2025; Nov 11 [Epub ahead of print].
Development and validation of EsoTIME, a prognostication tool for resected esophageal and gastroesophageal cancer
Harrison LD, Gupta V, Yuen M, Coburn NG, Pugliese M, Ekuma O, Derksen S, Compton C, Boyes R, Davis L, Decker K, Kidane B, Ringash J, Hsu AT, Mahar A; Population Registry of Esophageal and Stomach Tumours in Ontario (PRESTO) Group. Ann Surg Oncol. 2026; 33(2):955-966. Epub 2025 Oct 25.
Identifying potentially inappropriate prescribing in entire populations: coding the STOPP-START and Beers criteria for use with large, routinely collected population health datasets
Bjerre LM, Halil R, Catley C, Smith G, Ramsay T, Cahir C, Ryan C, Ferrell B, Thavorn K, Hawken S, Gillespie U, Manuel DG, Abdulaziz KE. J Clin Epidemiol. 2026; 189: 112019. Epub 2025 Oct 24.